Studies on mechanism of 8-methoxypsoralen-DNA interaction in the dark.

Abstract

The interaction of 8-methoxypsoralen (8-MOP) with calf thymus DNA was studied in darkness at 25 degrees C and pH 7.4. The enthalpy curve for 8-MOP-DNA interaction was obtained by isothermal titration calorimetry and showed a two-step process for the interaction. According to the spectrophotometric data, it was suggested that some compaction may occur in the DNA structure at higher [8-MOP](t)/[DNA] ratio. Using the fluorescence quenching data, the Scatchard analysis was performed for 8-MOP-DNA interaction at the extended ranges of drug concentration. The results indicated that the first set of binding sites was occupied by 1 mol of drug bound per near eight base pairs of DNA. Also 8-MOP caused the quenching of the fluorescence emission of DNA-ethidium bromide complex. The Scatchard analysis of these data indicated the non-competitive manner for quenching. A non-displacement based quenching mechanism has been suggested for this behavior. The circular dichroism spectra also confirmed the non-intercalative binding of 8-MOP at higher concentrations accompanied by some conformational changes in DNA structure. It has been suggested that at low drug load, 8-MOP binds to DNA as an intercalator, which is an endothermic process, whereas at higher ratios of [8-MOP](t)/[DNA], it binds to the outside of DNA, probably in the minor groove and causes some compaction in DNA, which is the exothermic process.

Statistics

0204060'05'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

90 Citations

Semantic Scholar estimates that this publication has 90 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Arabzadeh2002StudiesOM, title={Studies on mechanism of 8-methoxypsoralen-DNA interaction in the dark.}, author={Atefah Arabzadeh and Seyede Zahra Bathaie and Hassan Farsam and Massoud Amanlou and Ali Akbar Saboury and Abbas Shockravi and Ali Akbar Moosavi-Movahedi}, journal={International journal of pharmaceutics}, year={2002}, volume={237 1-2}, pages={47-55} }